Cabaletta Bio Financial Overview
Cabaletta Bio's market cap is currently $230.07M. The company's EPS TTM is $-0.44; its P/E ratio is -0.95; Cabaletta Bio is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
